Virexa
- Product NDC
- 85477-606
- 11-digit product format
- 854770606
- Labeler code
- 85477
- Product ID
- 85477-606_3e16048d-d854-563e-e063-6394a90a6600
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Vitamin C, Vitamin D3, Vitamin B1, Vitamin B6, Vitamin B12, Folic Acid, NADH, Ubiquinone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Oncora Pharma, LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2025-09-01
- Substance
- ASCORBIC ACID; CHOLECALCIFEROL; FOLIC ACID; METHYLCOBALAMIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; PYRIDOXAL PHOSPHATE ANHYDROUS; THIAMINE HCL; UBIQUINONE
- Active strength
- 125; 12.5; 1.667; 1; 5; 125; 25; 50 mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1
- Pharmacologic classes
- Ascorbic Acid [CS], Vitamin C [EPC], Vitamin D [CS], Vitamin D [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Virexa
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ASCORBIC ACID | 125 mg/1 |
| CHOLECALCIFEROL | 12.5 ug/1 |
| FOLIC ACID | 1.667 mg/1 |
| METHYLCOBALAMIN | 1 mg/1 |
| NICOTINAMIDE ADENINE DINUCLEOTIDE | 5 mg/1 |
| PYRIDOXAL PHOSPHATE ANHYDROUS | 125 mg/1 |
| THIAMINE HCL | 25 mg/1 |
| UBIQUINONE | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | PQ6CK8PD0R, 1C6V77QF41, 935E97BOY8, BR1SN1JS2W, 0U46U6E8UK, F06SGE49M6, M572600E5P, EJ27X76M46 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 85477-606-30 | Virexa | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 85477-606-30 | 85477060630 | 30 TABLET in 1 BOTTLE (85477-606-30) | 30 tablet | 2025-09-01 | No | No | Current |